Drawing for CELLFINITY

USPTO serial 79458982

CELLFINITY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with CELLFINITY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biochemical preparations for use in research and laboratories, in particular reagents for pharmacological research, chemical reagents for chromatographic immobilization, purification or isolation of biological materials; chemical reagents for chromatographic immobilization, purification or isolation of cells, in particular body cells and cells of the immune system of mammals including human cells; affinity chromatography reagents used in columns for immobilization, purification or isolation of cells, in particular for immobilization or purification of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and moncytes; chemical reagents for genetically modifying body cells, stem cells and cells of the immune system of mammals including human cells, T-cells, B-cells, natural killer cells and monocytes; chemical reagents for transferring genes into body cells, stem cells, and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes.ACTIVE—
005Pharmaceutical and veterinary preparations, in particular cells, in particular body cells, stem cells, and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; body cells, stem cells, and cells of the immune systems for treatment of cancerous diseases, autoimmune diseases, viral infections or bacterial infections, genetically modified human immune cells, including T-cells, B-cells, natural killer cells or monocytes for treatment of cancerous diseases, autoimmune diseases, viral infections or bacterial infections, in vivo diagnostic reagents for medical purposes.ACTIVE—
009Scientific apparatus for the chromatographic immobilization, purification or isolation of biological materials; chromatography columns; scientific apparatus for the chromatographic immobilization, purification or isolations of cells, in particular body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; scientific apparatus for the transfer of genes into body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes.ACTIVE—
042Scientific services and research relating thereto in the fields of biology, chemistry, medicine, immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, in particular cellular therapy products, including body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes, diagnostic preparations and biomarker reagents and/or diagnostic apparatus.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 25, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 25, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 24, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance